(Q36203352)

12 August 2017

1 reference

title

Treatment of osteoporosis in chronic kidney disease and end-stage renal disease (English)

1 reference

chronic renal insufficiency

12 August 2017

main subject

1 reference

Paul D Miller

1

1 reference

12 August 2017

publication date

1 March 2005

1 reference

Current osteoporosis reports

12 August 2017

published in

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

5-12

1 reference

https://scigraph.springernature.com/pub.10.1007/s11914-005-0021-y

12 August 2017

exact match

0 references

cites work

Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-005-0021-Y

Osteoporosis in chronic kidney disease.

21 January 2018

1 reference

12 December 2020

Risk factors for hip fracture among patients with end-stage renal disease

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Bone microstructure in osteoporosis: transilial biopsy and histomorphometry

1 reference

12 December 2020

Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry

1 reference

12 December 2020

Renal failure associated with intravenous diphosphonates

1 reference

12 December 2020

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

12 December 2020

Bisphosphonates: a review of their pharmacokinetic properties

1 reference

12 December 2020

Bone biopsy and histomorphometry in clinical practice

1 reference

12 December 2020

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis

1 reference

12 December 2020

Alendronate for the Treatment of Osteoporosis in Men

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Risk factors for reduced bone density in haemodialysis patients

1 reference

12 December 2020

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

12 December 2020

Pathophysiology and recent advances in the management of renal osteodystrophy

1 reference

12 December 2020

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

12 December 2020

Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy

1 reference

12 December 2020

Risk factors for vertebral fractures in renal osteodystrophy

1 reference

12 December 2020

Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels.

1 reference

12 December 2020

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

1 reference

12 December 2020

Relationship between age, renal function and bone mineral density in the US population

1 reference

12 December 2020

Assessment of renal function in the old. Special considerations.

1 reference

12 December 2020

The pharmacology of bisphosphonates and new insights into their mechanisms of action

1 reference

12 December 2020

Osteoporosis in end-state renal disease.

1 reference

12 December 2020

Bisphosphonates: from the laboratory to the clinic and back again

1 reference

12 December 2020

Factors affecting renal function in 119 985 adults over three years

1 reference

12 December 2020

Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

1 reference

12 December 2020

Osteodystrophy in the millennium.

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

Risk of hip fracture among dialysis and renal transplant recipients

1 reference

12 December 2020

Renal Failure with the Use of Zoledronic Acid

1 reference

12 December 2020

Renal secretion of diphosphonates in rats

1 reference

12 December 2020

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience

1 reference

12 December 2020

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

12 December 2020

The role of bone biopsy in clinical practice and research.

1 reference

12 December 2020

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

10.1007/S11914-005-0021-Y

Identifiers

DOI

1 reference

12 August 2017

1 reference